LORENZO BELLO
Prof. Lorenzo Bello, in Humanitas Research Hospital since 2011, is Cancer Neurosurgery Unit Director. He has gained significant experience abroad, particularly at Brigham and Women’s Hospital, Harvard Medical School in Boston. He is also responsible for the Brain mapping group and the Surgical Epilepsy group at the University of Milan.
Confira a agenda de atividades
22 DE MARÇO | SEXTA-FEIRA
• Room 1
13:30-15:30
SESSION 2: GLIOMAS
Radiomics to predict MGMT, IDH mutations and EGFR amplifications
Understanding the radiotherapy effects in glioma oncogenesis
Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement
Challenges of insular gliomas surgery
Beyond boundaries: exploring the impact of supratotal resection on diffuse gliomas
The role of re-irradiation for recurrent adult-type diffuse gliomas
Update on antiepileptic drugs use for glioma's patients
Discussion
Moderator: Daniel Andrade Gripp (SP)
Moderator: Iuri Santana Neville Ribeiro (SP)
Moderator: Fabiana Spillari Viola (RS)
Radiomics to predict MGMT, IDH mutations and EGFR amplifications
Speaker: Rajan Jain (Estados Unidos)
Understanding the radiotherapy effects in glioma oncogenesis
Speaker: Fabio Ynoe de Moraes (Canadá)
Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement
Speaker: Roger Stüpp (Estados Unidos)
Challenges of insular gliomas surgery
Speaker: Frederick F. Lang (Estados Unidos)
Beyond boundaries: exploring the impact of supratotal resection on diffuse gliomas
Speaker: Lorenzo Bello (Itália)
The role of re-irradiation for recurrent adult-type diffuse gliomas
Speaker: Andre Tsin Chih Chen (SP)
Update on antiepileptic drugs use for glioma's patients
Speaker: Gabriel Novaes de Rezende Batistella (SP)
Discussion
15:50-17:30
PLENARY SESSION 2
Awake glioma surgery: technical evolutions and nuances
The role of liquid biopsy in neuro-oncology
How can NGS affect prognosis and treatment for diffuse gliomas?
Radiogenomics in gliomas
SNO Institutional Presentation
Moderator: Rodrigo Ferrari Fernandes Naufal (SP)
Moderator: Daniel Marques (DF)
Moderator: José Marcus Rotta (SP)
Awake glioma surgery: technical evolutions and nuances
Speaker: Lorenzo Bello (Itália)
The role of liquid biopsy in neuro-oncology
Speaker: Francisco Martínez Ricarte (Espanha)
How can NGS affect prognosis and treatment for diffuse gliomas?
Speaker: Roger Stüpp (Estados Unidos)
Radiogenomics in gliomas
Speaker: Rajan Jain (Estados Unidos)
SNO Institutional Presentation
Speaker: Chas Haynes (Estados Unidos)
23 DE MARÇO | SÁBADO
• Room 1
13:30-15:30
SESSION 4: DIFFUSE GLIOMAS
A Critical Overview of Targeted Therapies for Glioma
Translational research for gliomas: future landscapes and emerging paradigm
The role of CAR T cell therapy in neurooncology
What we do know about non-standard of care treatments for gliomas: cannabis, antidepressants, metformin and others
Bevacizumab, is there still a role for antiangiogenics in glioblastoma?
The optimal timing of palliative care in glioma patients
How feasible is surgery in the motor area?
Discussion
Moderator: ícaro Thiago de Carvalho (SP)
A Critical Overview of Targeted Therapies for Glioma
Speaker: Tracy Batchelor (Estados Unidos)
Translational research for gliomas: future landscapes and emerging paradigm
Speaker: Vinay K. Puduvalli (Estados Unidos)
The role of CAR T cell therapy in neurooncology
Speaker: Andreas Hottinger (Suíça)
What we do know about non-standard of care treatments for gliomas: cannabis, antidepressants, metformin and others
Speaker: Yvonne Kew (Estados Unidos)
Bevacizumab, is there still a role for antiangiogenics in glioblastoma?
Speaker: Juan Sepulveda (Espanha)
The optimal timing of palliative care in glioma patients
Speaker: Daniel Neves Forte (SP)
How feasible is surgery in the motor area?
Speaker: Lorenzo Bello (Itália)
Discussion
Realização
Organização
agência de turismo
PATROCÍNIO PRATA
PATROCÍNIO BRONZE
APOIO
Apoio Institucional
